Life Sciences and Healthcare.

Our Team assists innovative biotechnology companies, clinical research companies and industry investors in a broad range of business activities, including but not limited to fundraising and listing on the Hong Kong Stock Exchange.

Our full-service offerings include:

• R&D collaborations
• Review company structure and advise on its suitability for listing;
• Review the development stage of the company’s core product(s) and examine its readiness for listing;
• Advise on corporate restructuring to comply with listing rules;
• Facilitate IPO application to meet the new minimum expected market capitalisation;
• Prepare listing documents and liaise with the Exchange to resolve any queries that they may have;
• On-going compliance with all disclosure and regulatory requirements under Hong Kong Law.